| Net income | 101.24M |
| Depreciation and amortization | 81.17M |
| Stock-based compensation | 89.91M |
| Amortization of acquired intangible assets | |
| Facilities impairment | |
| Other (income) expense, net | 1.02M |
| Fair market value adjustment to aquired inventory sold | |
| Excess tax benefits from stock-based compensation | -10K |
| Deferred income taxes | |
| Accounts receivable | -38.9M |
| Inventories | 10.94M |
| Prepaid expenses and other assets | -2.58M |
| Accounts payable | 10.54M |
| Accrued liabilities and other | -23.74M |
| Accrued employee compensation | 10.42M |
| Deferred income | 7.93M |
| Net cash provided by operating activities | |
| Purchases of marketable securities | |
| Purchases of strategic investments | |
| Sales and maturities of investments | |
| Cash paid for acquisition, net | |
| Purchases of technology licenses | -8.44M |
| Purchases of property and equipment | -37.72M |
| Net cash used in investing activities | |
| Repurchase of common stock | -56.53M |
| Proceeds from employee stock plans | |
| Principal payments on capital lease obligations | |
| Excess tax benefits from stock-based compensation | 10K |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | -526.59M |
| Cash and cash equivalents at beginning of period | 1.28B |
| Cash and cash equivalents at end of period | 751.59M |